A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment (Q36716739)
Jump to navigation
Jump to search
scientific article published on 24 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment |
scientific article published on 24 April 2015 |
Statements
1 reference
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment (English)
1 reference
Barbara Jarzab
1 reference
Bruce Robinson
1 reference
Maria E Cabanillas
1 reference
Martin Schlumberger
1 reference
Renato G Martins
1 reference
Furio Pacini
1 reference
Judith C McCaffrey
1 reference
Manisha H Shah
1 reference
Donald L Bodenner
1 reference
Corina Andresen
1 reference
James P O'Brien
1 reference
Min Ren
1 reference
Yasuhiro Funahashi
1 reference
Roger Allison
1 reference
Kate Newbold
1 reference
Douglas W Ball
1 reference
24 April 2015
1 reference
1 reference
2749-2756
1 reference
Identifiers
1 reference
1 reference
1 reference